<DOC>
	<DOCNO>NCT00203112</DOCNO>
	<brief_summary>This study investigate add-on effect oral minocycline subject treat daily injection Copaxone . Copaxone minocycline think differential mode action may complement treat MS symptom .</brief_summary>
	<brief_title>Safety Efficacy Study Copaxone Administered Combination With Minocycline</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<mesh_term>Glatiramer Acetate</mesh_term>
	<criteria>1 . Clinically definite MS define Poser et al . ( Ann . Neurol . 1983 ) disease duration ( onset ) least 6 month . 2 . Subjects must relapsingremitting disease course . 3 . Subjects must least 1 documented relapse within last year prior study entry . 4 . Subjects must least 1 15 gadolinium ( Gd ) enhance lesion screen MRI scan . 5 . Subjects must relapsefree take corticosteroid ( IV , IM and/or PO ) within 30 day prior screen visit . 6 . Subjects may male female . Women child bear potential must use contraceptive method deem reliable investigator . 7 . Subjects must age 18 50 year inclusive . 8 . Subjects must ambulatory , Kurtzke EDSS score 0 5.0 inclusive . 9 . Subjects must willing able give write informed consent prior enter study . 1 . Previous use injectable glatiramer acetate . 2 . Previous use cladribine . 3 . Previous use immunosuppressive agent last 6 month . 4 . Use experimental investigational drug , include I.V . immunoglobulin statin , within 6 month prior study entry . 5 . Use interferon agent minocycline within 4 month prior screen visit . 6 . Chronic corticosteroid ( IV , IM and/or PO ) treatment ( 30 consecutive day ) 6 month prior study entry . 7 . Previous total body irradiation total lymphoid irradiation ( TLI ) . 8 . Pregnancy breast feed . 9 . Subjects experience relapse screening ( month 1 ) baseline ( month 0 ) visit . 10 . Significant medical psychiatric condition affect subject 's ability give inform consent , complete study , condition investigator feel may interfere participation study ( e.g . alcohol drug abuse ) . 11 . A known history sensitivity mannitol . 12 . Contraindication know history sensitivity tetracycline . 13 . A known history sensitivity gadolinium . 14 . Inability successfully undergo MRI scanning .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>